| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
We investigated the development and maintenance of proliferative and antibody responses to apical membrane antigen-1 (AMA-1) epitopes in a holoendemic area of western Kenya. Young children (< 10 years), older children (10-17 years), and adults (> or = 18 years) were followed longitudinally for antibody and T-cell responses at 3 time points with an interval of 3-4 months. The proliferative responses against the AMA-1 T epitopes (PL171, PL172, PL173, PL186, PL191, and PL192) were not stable during follow-up; however, response to mycobacterial antigen PPD was highly stable. The responder frequencies were similar in all 3 time points except for epitope PL192. The younger and older children responded more frequently to T-cell epitopes, but the differences were not significant. A positive proliferative response to PL191 was associated with a significantly lower risk of parasitemia at subsequent follow-up (relative risk, 0.5; P = 0.03). The presence of antibody response to B epitopes PL169, PL170, PL173, PL187, and PL192 in one time point was associated with a subsequent response (P = 0.0001-0.008) suggesting a stable response. Younger (P = 0.046) and older children (P = 0.017) more frequently responded to epitope PL169 than did adults, and adults responded more frequently to PL187 than did younger children (P = 0.009). Responses to AMA-1 T-cell epitopes were short lived, and antibody responses were relatively stable.
This article has been cited by other articles:
|
|
 |
|
  K. Miura, H. Zhou, O. V. Muratova, A. C. Orcutt, B. Giersing, L. H. Miller, and C. A. Long In Immunization with Plasmodium falciparum Apical Membrane Antigen 1, the Specificity of Antibodies Depends on the Species Immunized Infect. Immun., December 1, 2007; 75(12): 5827 - 5836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. MORAIS, I. S. SOARES, L. H. CARVALHO, C. J. F. FONTES, A. U. KRETTLI, and E. M. BRAGA ANTIBODIES TO PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1: PERSISTENCE AND CORRELATION WITH MALARIA TRANSMISSION INTENSITY. Am J Trop Med Hyg, October 1, 2006; 75(4): 582 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wickramarachchi, P. H. Premaratne, K. L. R. L. Perera, S. Bandara, C. H. M. Kocken, A. W. Thomas, S. M. Handunnetti, and P. V. Udagama-Randeniya Natural Human Antibody Responses to Plasmodium vivax Apical Membrane Antigen 1 under Low Transmission and Unstable Malaria Conditions in Sri Lanka Infect. Immun., January 1, 2006; 74(1): 798 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Bonner, Z. Zhou, L. B. Mirel, J. G. Ayisi, Y. P. Shi, A. M. van Eijk, J. A. Otieno, B. L. Nahlen, R. W. Steketee, and V. Udhayakumar Placental Malaria Diminishes Development of Antibody Responses to Plasmodium falciparum Epitopes in Infants Residing in an Area of Western Kenya Where P. falciparum Is Endemic Clin. Vaccine Immunol., March 1, 2005; 12(3): 375 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Mitchell, A. W. Thomas, G. Margos, A. R. Dluzewski, and L. H. Bannister Apical Membrane Antigen 1, a Major Malaria Vaccine Candidate, Mediates the Close Attachment of Invasive Merozoites to Host Red Blood Cells Infect. Immun., January 1, 2004; 72(1): 154 - 158. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
